Trial Profile

The effects of subcutaneous insulin detemir on glucose flux, pharmacokinetics and brain function in type one diabetes

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 13 Oct 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin detemir (Primary) ; Insulin suspension isophane (Primary)
Indications Type 1 diabetes mellitus
Focus Pharmacodynamics

Most Recent Events

25 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
25 Jun 2013 Status changed from recruiting to completed, based on presentation of results.
06 Oct 2011 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com